ASBP Aspire BioPharma, Inc.
Company Analysis
Latest News
🔴 Aspire BioPharma is trading 5.71% down today with no clear catalyst
Aspire BioPharma is trading 5.71% down at $5.45 in pre-market after a weak follow-through from the prior session’s $5.78 close. • No company-specific...
🔴 ASBP is trading 9.9% down today as it extends pullback from late-June speculative gains
ASBP is trading 9.9% down at $5.30 as the stock extends its recent pullback from late-June speculative gains and financing-driven volatility. • The move...
🔴 ASBP is trading 5.2% down today in a pullback after recent speculative gains
ASBP is trading at $5.89 (5.2% down) in pre-market as the stock pulls back from a recent volatile stretch. • The decline follows a period of sharp gains tied...
🔴 ASBP is trading 6.3% down today on profit-taking and broader market softness
ASBP is trading at $5.49, down 6.3% today as the stock gives back a portion of its recent sharp rally. • The stock surged 9.74% on July 01, 2026, but faced...
🔴 ASBP is trading 6% down today on profit-taking after a regular-session rally
ASBP is trading at $5.51, down 5.97% in after-hours trading, as the stock gives back a portion of its 9.74% regular-session gain amid broader market...
🟢 ASBP is trading 5.3% up today as traders refocus on FDA pre-IND optimism
ASBP is trading 5.3% up at $5.62 as the stock rebounds from a sharp drop in the prior session linked to concerns over its planned acquisition of Dura Driver...
🟢 ASBP is trading 6.7% up today as it recovers from acquisition concerns and eyes FDA momentum
ASBP is trading 6.7% up at $5.70 in pre-market, bouncing after yesterday’s sharp drop tied to fading optimism around its planned Dura Driver Control Systems...
🔴 ASBP is trading 13.19% down today as momentum traders unwind following fading enthusiasm for the Dura Driver deal
ASBP is trading at $5.33 (-13.19%) as momentum traders unwind a volatile rally following fading enthusiasm for the planned Dura Driver Control Systems...
Aspire BioPharma Jumps 13% on Dura Driver Deal Buzz, but Can a Biotech With No Revenue Really Digest a $200M Auto Supplier?
Shares of Aspire BioPharma (ASBP) surged 13.1% to $6.94 on Monday as momentum traders piled into the micro-cap stock, extending a volatile run fueled by the...
🟢 ASBP is trading 13.1% up today on momentum following successful private placement and funding for planned Dura Driver acquisition
• ASBP is trading at $6.94 (up 13.1%) as the stock gains traction following a successful $21 million private placement on June 28, which boosted shareholder...
🟢 ASBP is trading 6.7% up today as traders buy the dip ahead of Life Sciences Investor Forum presentation
ASBP is trading at $6.40 (6.7% up) in after-hours trading as investors buy the dip following a sharp intraday pullback. • The stock is rebounding from a 7.1%...
🔴 ASBP is trading 6.9% down today as post-launch rally fades ahead of investor forum
ASBP is trading 6.9% down at $6.01 as the stock extends a pullback following its recent Amazon launch and ahead of a planned presentation at the Life Sciences...
🔴 ASBP is trading 6.2% down today as stock pulls back following BUZZ BOMB Amazon launch
ASBP is trading at $6.05, down 6.2%, as the stock extends a pullback following its recent BUZZ BOMB Amazon launch and planned Life Sciences Investor Forum...
🔴 ASBP is trading 5.4% down today following its BUZZ BOMB Amazon launch and investor forum presentation
ASBP is trading 5.4% down at $6.19 as it gives back part of its recent rally tied to the BUZZ BOMB Amazon launch and its planned Life Sciences Investor Forum...
🔴 ASBP is trading 5.05% down today following a rally tied to product launch and investor forum news
ASBP is trading 5.05% down at $6.21 following the June 24 regular-session close, retracing gains after a rally driven by recent product and investor event...
🟢 ASBP is trading 7% up today on Amazon Buzz Bomb launch and ahead of Life Sciences Investor Forum appearance
ASBP is trading 7% up at $6.60 today, driven by the nationwide Amazon launch of its innovative BUZZ BOMB™ 50mg caffeine stick packs and ahead of its scheduled...
🔴 ASBP makes sharp 12.6% drop
ASBP is trading at $5.50, down 12.6% versus the comparison close of $6.29 during pre-market. This is a price-movement alert; no separate company-specific...
🔴 ASBP is trading 5.3% down today on dilution concerns from warrant exercise approval
ASBP is trading 5.3% down at $5.96 in pre-market following shareholder approval of warrant exercises and share issuance. • The June 16, 2026, approval has...
Aspire Biopharma Stockholders Approve Proposals for Warrant Exercise and Share Issuance
Aspire Biopharma Holdings, Inc. announced that stockholders approved three proposals related to outstanding warrants at a Special Meeting held on June 16,...
🔴 Aspire BioPharma, Inc. is trading 5.3% down today as traders digest its strategic pivot
Aspire BioPharma, Inc. is trading 5.3% down at $6.23 as investors continue to evaluate the company's recent strategic pivot following the Dura Driver Control...